Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 138.64M | € 127.28M | € 172.72M | € 49.30M | € 112.40M |
Total Assets | € 2.40B | € 2.39B | € 1.81B | € 1.52B | € 1.45B |
Total Debt | € 1.02B | € 1.02B | € 705.57M | € 483.04M | € 513.22M |
Net Debt | € 880.47M | € 892.87M | € 532.85M | € 433.74M | € 400.82M |
Total Liabilities | € 1.18B | € 1.20B | € 823.77M | € 593.17M | € 607.07M |
Stockholders Equity | € 1.21B | € 1.19B | € 982.58M | € 926.53M | € 845.58M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |